5-Mar-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on
26-Feb-2025 3:04 PM CST - Business Wire Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the fourth quarter and full year ended December 31, 2024, and highlighted select corporate progress and achievements. Pavel Raifeld,
6-Feb-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a podium presentation at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
26-Nov-2024 6:00 AM CST - Business Wire Innoviva to Participate in the Citi 2024 Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, FL on Thursday,
12-Nov-2024 3:05 PM CST - Business Wire Innoviva to Participate in the UBS Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference in Ranch Palos Verdes, CA on Wednesday, November 13, 2024 at
6-Nov-2024 3:05 PM CST - Business Wire Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2024, and highlighted select corporate achievements. For the third quarter of 2024, we contin
5-Mar-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on
26-Feb-2025 3:04 PM CST - Business Wire Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the fourth quarter and full year ended December 31, 2024, and highlighted select corporate progress and achievements. Pavel Raifeld,
6-Feb-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a podium presentation at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
26-Nov-2024 6:00 AM CST - Business Wire Innoviva to Participate in the Citi 2024 Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, FL on Thursday,
12-Nov-2024 3:05 PM CST - Business Wire Innoviva to Participate in the UBS Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference in Ranch Palos Verdes, CA on Wednesday, November 13, 2024 at
6-Nov-2024 3:05 PM CST - Business Wire Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2024, and highlighted select corporate achievements. For the third quarter of 2024, we contin
